Concepedia

Kevin J. Milliner

KJ

Statistics

Publications

11

Citations

1K

H-Index

11

Active since

1985

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Molecular Discovery (United Kingdom)

University of Reading

Kevin J. Milliner is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacology, phospholipase a2 pathway, and enzyme inhibition.

Publications per year

1985–2003

11

Publications

11

Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor

Colin H. Macphee, Kitty Moores, Helen Boyd et al. · Biochemical Journal · 1999 · 337 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Lipoprotein-Associated Phospholipase A <sub>2</sub> , Platelet-Activating Factor Acetylhydrolase, Is Expressed by Macrophages in Human and Rabbit Atherosclerotic Lesions

Tomi Häkkinen, Jukka Luoma, Mikko Hiltunen et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1999 · 245 citations

Life Sciences, Biochemistry, Molecular Biology +16

The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2

Josie A. Blackie, Jackie C. Bloomer, Murray J. B. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 130 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor

Colin H. Macphee, Kitty Moores, Helen Boyd et al. · Biochemical Journal · 1999 · 102 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Studies on the mechanism of action of omeprazole

David J. Keeling, Colin Fallowfield, Kevin J. Milliner et al. · Biochemical Pharmacology · 1985 · 73 citations

Medicine, Pharmacology, Pharmacotherapy +9

1–5 of 11